Clinical Mycology Today: Emerging Challenges and Opportunities.

Autor: Little J; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Rauseo AM; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Zuniga-Moya JC; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Spec A; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Pappas P; Division of Infectious Diseases, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA., Perfect J; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., McCarthy T; Division of Infectious Diseases, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA., Schwartz IS; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Jazyk: angličtina
Zdroj: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jun 27; Vol. 11 (7), pp. ofae363. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).
DOI: 10.1093/ofid/ofae363
Abstrakt: The Mycoses Study Group Education and Research Consortium is a collective of clinicians, researchers, and educators with the common goal to advance awareness, diagnosis, and management of invasive fungal diseases. Clinical Mycology Today, the Mycoses Study Group Education and Research Consortium's biennial meeting, is dedicated to discussing the most pressing contemporary issues facing the field of clinical mycology, promoting clinical, translational, and basic science collaborations, and mentoring the next generation of clinical mycologists. Here, we review the current opportunities and challenges facing the field of mycology that arose from discussions at the 2022 meeting, with emphasis on novel host risk factors, emerging resistant fungal pathogens, the evolving antifungal pipeline, and critical issues affecting the advancement of mycology research.
(© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje